Deep and superficial keloid fibroblasts contribute differentially to tissue phenotype in a novel in vivo model of keloid scar

Plastic and Reconstructive Surgery

Volumn 129, Issue 6, 2012, Pages 1259-1271

  Supp, Dorothy M ^a,b   Hahn, Jennifer M ^a,b   Glaser, Kathryn ^a,b   McFarland, Kevin L ^a,b   Boyce, Steven T ^a,b  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE I, ALPHA 1 CHAIN;

ADOLESCENT; ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CHILD; COMPARATIVE STUDY; DISEASE MODEL; FEMALE; FIBROBLAST; HUMAN; KELOID; KERATINOCYTE; MALE; METABOLISM; METHODOLOGY; MOUSE; NUDE MOUSE; PATHOLOGY; PHENOTYPE; SKIN TRANSPLANTATION; TISSUE ENGINEERING; WOUND HEALING;

ADOLESCENT; ANIMALS; CELLS, CULTURED; CHILD; COLLAGEN TYPE I; DISEASE MODELS, ANIMAL; FEMALE; FIBROBLASTS; HUMANS; KELOID; KERATINOCYTES; MALE; MICE; MICE, NUDE; PHENOTYPE; SKIN TRANSPLANTATION; TISSUE ENGINEERING; WOUND HEALING;

EID: 84861721708     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e31824ecaa9     Document Type: Conference Paper

References (61)

1. Bran GM, Goessler UR, Hormann K, Riedel F, Sadick H. Keloids: Current concepts of pathogenesis (Review). Int J Mol Med. 2009;24:283-293.
2. Shih B, Bayat A. Genetics of keloid scarring. Arch Dermatol Res. 2010;302:319-339.
3. Marneros AG, Norris JE, Olsen BR, Reichenberger E. Clinical genetics of familial keloids. Arch Dermatol. 2001;137:1429-1434.
4. Butler PD, Longaker MT, Yang GP. Current progress in keloid research and treatment. J Am Coll Surg. 2008;206:731-741.
5. Bella H, Heise M, Yagi KI, Black G, McGrouther DA, Bayat A. A clinical characterization of familial keloid disease in unique African tribes reveals distinct keloid phenotypes. Plast Reconstr Surg. 2011;127:689-702.
6. Sidgwick GP, Bayat A. Extracellular matrix molecules implicated in hypertrophic and keloid scarring. J Eur Acad Dermatol Venereol. 2012;26:141-152.
7. Bock O, Schmid-Ott G, Malewski P, Mrowietz U. Quality of life of patients with keloid and hypertrophic scarring. Arch Dermatol Res. 2006;297:433-438.
8. Van Loey NE, Van Son MJ. Psychopathology and psychological problems in patients with burn scars: Epidemiology and management. Am J Clin Dermatol. 2003;4:245-272.
9. Olaitan PB. Keloids: Assessment of effects and psychosocialimpacts on subjects in a black African population. Indian J Dermatol Venereol Leprol. 2009;75:368-372.
10. Furtado F, Hochman B, Ferrara SF, et al. What factors affect the quality of life of patients with keloids? Rev Assoc Med Bras. 2009;55:700-704.
11. Alster TS, Tanzi EL. Hypertrophic scars and keloids: Etiology and management. Am J Clin Dermatol. 2003;4:235-243.
12. Murray JC. Keloids and hypertrophic scars. Clin Dermatol. 1994;12:27-37.
13. English RS, Shenefelt PD. Keloids and hypertrophic scars. Dermatol Surg. 1999;25:631-638.
14. Al-Attar A, Mess S, Thomassen JM, Kauffman CL, Davison SP. Keloid pathogenesis and treatment. Plast Reconstr Surg. 2006; 117:286-300.
15. Zhu KQ, Engrav LH, Tamura RN, et al. Further similarities between cutaneous scarring in the female, red Duroc pig and human hypertrophic scarring. Burns 2004;30:518-530.
16. Zhu KQ, Engrav LH, Gibran NS, et al. The female, red Duroc pig as an animal model of hypertrophic scarring and the potential role of the cones of skin. Burns 2003;29:649-664.
17. Morris DE, Wu L, Zhao LL, et al. Acute and chronic animal models for excessive dermal scarring: Quantitative studies. Plast Reconstr Surg. 1997;100:674-681.
18. Wang J, Ding J, Jiao H, et al. Human hypertrophic scar-like nude mouse model: Characterization of the molecular and cellular biology of the scar process. Wound Repair Regen. 2011;19:274-285.
19. Hillmer MP, MacLeod SM. Experimental keloid scar models: A review of methodological issues. J Cutan Med Surg. 2002; 6:354-359.
20. Robb EC, Waymack JP, Warden GD, Nathan P, Alexander JW. A new model for studying the development of human hypertrophic burn scar formation. J Burn Care Rehabil. 1987; 8:371-375.
21. Estrem SA, Domayer M, Bardach J, Cram AE. Implantation of human keloid tissue into athymic mice. Laryngoscope 1987; 97:1214-1218.
22. Fujiwara M, Muragaki Y, Ooshima A. Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration. Br J Dermatol. 2005;153:295-300.
23. Garner WL. Epidermal regulation of dermal fibroblast activity. Plast Reconstr Surg. 1998;102:135-139.
24. Lim IJ, Phan TT, Song C, Tan WT, Longaker MT. Investigation of the influence of keloid-derived keratinocytes on fibroblast growth and proliferation in vitro. Plast Reconstr Surg. 2001;107:797-808.
25. Phan TT, Lim IJ, Bay BH, et al. Differences in collagen production between normal and keloid-derived fibroblasts in serum-media co-culture with keloid-derived keratinocytes. J Dermatol Sci. 2002;29:26-34.
26. Funayama E, Chodon T, Oyama A, Sugihara T. Keratinocytes promote proliferation and inhibit apoptosis of the underlying fibroblasts: An important role in the pathogenesis of keloid. J Invest Dermatol. 2003;121:1326-1331.
27. Lim IJ, Phan TT, Bay BH, et al. Fibroblasts cocultured with keloid keratinocytes: Normal fibroblasts secrete collagen in a keloidlike manner. Am J Physiol Cell Physiol. 2002;283:C212-C222.
28. Mukhopadhyay A, Tan EK, Khoo YT, Chan SY, Lim IJ, Phan TT. Conditioned medium from keloid keratinocyte/keloid fibroblast coculture induces contraction of fibroblast-populated collagen lattices. Br J Dermatol. 2005;152:639-645.
29. Phan TT, Lim IJ, Bay BH, et al. Role of IGF system of mitogens in the induction of fibroblast proliferation by keloidderived keratinocytes in vitro. Am J Physiol Cell Physiol. 2003; 284:C860-C869.
30. Butler PD, Ly DP, Longaker MT, Yang GP. Use of organotypic coculture to study keloid biology. Am J Surg. 2008;195: 144-148.
31. Boyce ST, Goretsky MJ, Greenhalgh DG, Kagan RJ, Rieman MT, Warden GD. Comparative assessment of cultured skin substitutes and native skin autograft for treatment of fullthickness burns. Ann Surg. 1995;222:743-752.
32. Boyce ST, Glatter R, Kitzmiller WJ. Treatment of chronic wounds with cultured cells and biopolymers: A pilot study. Wounds 1995;7:24-29.
33. Boyce ST, Kagan RJ, Meyer NA, Yakuboff KP, Warden GD. The 1999 clinical research award: Cultured skin substitutes combined with Integra Artificial Skin to replace native skin autograft and allograft for closure of full-thickness burns. J Burn Care Rehabil. 1999;20:453-461.
34. Boyce ST, Kagan RJ, Yakuboff KP, et al. Cultured skin substitutes reduce donor skin harvesting for closure of excised, full-thickness burns. Ann Surg. 2002;235:269-279.
35. Boyce ST, Hansbrough JF. Biologic attachment, growth, and differentiation of cultured human epidermal keratinocytes on a graftable collagen and chondroitin-6-sulfate substrate. Surgery 1988;103:421-431.
36. Boyce ST, Kagan RJ, Greenhalgh DG, et al. Cultured skin substitutes reduce requirements for harvesting of skin autograft for closure of excised, full-thickness burns. J Trauma 2006;60:821-829.
37. Boyce ST, Supp AP, Harriger MD, Greenhalgh DG, Warden GD. Topical nutrients promote engraftment and inhibit wound contraction of cultured skin substitutes in athymic mice. J Invest Dermatol. 1995;104:345-349.
38. Boyce ST, Supp AP, Harriger MD, Pickens WL, Wickett RR, Hoath SB. Surface electrical capacitance as a noninvasive index of epidermal barrier in cultured skin substitutes in athymic mice. J Invest Dermatol. 1996;107:82-87.
39. Goretsky MJ, Harriger MD, Supp AP, Greenhalgh DG, Boyce ST. Expression of interleukin 1alpha, interleukin 6, and basic fibroblast growth factor by cultured skin substitutes before and after grafting to full-thickness wounds in athymic mice. J Trauma 1996;40:894-899; discussion 899-900.
40. Harriger MD, Supp AP, Warden GD, Holder IA. Effective management of microbial contamination in cultured skin substitutes after grafting to athymic mice. Wound Repair Regen. 1997;5:191-197.
41. Supp AP, Wickett RR, Swope VB, Harriger MD, Hoath SB, Boyce ST. Incubation of cultured skin substitutes in reduced humidity promotes cornification in vitro and stable engraftment in athymic mice. Wound Repair Regen. 1999;7:226-237.
42. Boyce ST, Supp AP, Swope VB, Warden GD. Vitamin C regulates keratinocyte viability, epidermal barrier, and basement membrane in vitro, and reduces wound contraction after grafting of cultured skin substitutes. J Invest Dermatol. 2002;118:565-572.
43. Varkey M, Ding J, Tredget EE. Differential collagen-glycosaminoglycan matrix remodeling by superficial and deep dermal fibroblasts: Potential therapeutic targets for hypertrophic scar. Biomaterials 2011;32:7581-7591.
44. Seifert O, Bayat A, Geffers R, et al. Identification of unique gene expression patterns within different lesional sites of keloids. Wound Repair Regen. 2008;16:254-265.
45. Boyce ST. Methods for serum-free culture of keratinocytes and transplantation of collagen-GAG based composite grafts. In: Morgan JR, Yarmush M, eds. Methods in Tissue Engineering. Totowa, NJ: Humana Press; 1998:365-389.
46. McFarland KL, Glaser K, Hahn JM, Boyce ST, Supp DM. Culture medium and cell density impact gene expression in normal skin and abnormal scar-derived fibroblasts. J Burn Care Res. 2011;32:498-508.
47. Smiley AK, Klingenberg JM, Aronow BJ, Boyce ST, Kitzmiller WJ, Supp DM. Microarray analysis of gene expression in cultured skin substitutes compared with native human skin. J Invest Dermatol. 2005;125:1286-1301.
48. Klingenberg JM, McFarland KL, Friedman AJ, Boyce ST, Aronow BJ, Supp DM. Engineered human skin substitutes undergo large-scale genomic reprogramming and normal skin-like maturation following transplantation to athymic mice. J Invest Dermatol. 2010;130:587-601.
49. Boyce ST, Foreman TJ, English KB, et al. Skin wound closure in athymic mice with cultured human cells, biopolymers, and growth factors. Surgery 1991;110:866-876.
50. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta-delta C(T)) method. Methods 2001;25:402-408.
51. Uitto J, Perejda AJ, Abergel RP, Chu ML, Ramirez F. Altered steady-state ratio of type I/III procollagen mRNAs correlates with selectively increased type I procollagen biosynthesis in cultured keloid fibroblasts. Proc Natl Acad Sci USA. 1985;82: 5935-5939.
52. Harriger MD, Warden GD, Greenhalgh DG, Kagan RJ, Boyce ST. Pigmentation and microanatomy of skin regenerated from composite grafts of cultured cells and biopolymers applied to full-thickness burn wounds. Transplantation 1995; 59:702-707.
53. Supp DM, Boyce ST. Overexpression of vascular endothelial growth factor accelerates early vascularization and improves healing of genetically modified cultured skin substitutes. J Burn Care Rehabil. 2002;23:10-20.
54. Harriger MD, Supp AP, Warden GD, Boyce ST. Glutaraldehyde crosslinking of collagen substrates inhibits degradation in skin substitutes grafted to athymic mice. J Biomed Mater Res. 1997;35:137-145.
55. Sorrell JM, Baber MA, Caplan AI. Site-matched papillary and reticular human dermal fibroblasts differ in their release of specific growth factors/cytokines and in their interaction with keratinocytes. J Cell Physiol. 2004;200:134-145.
56. Sorrell JM, Caplan AI. Fibroblast heterogeneity: More than skin deep. J Cell Sci. 2004;117:667-675.
57. Wang J, Dodd C, Shankowsky HA, Scott PG, Tredget EE; Wound Healing Research Group. Deep dermal fibroblasts contribute to hypertrophic scarring. Lab Invest. 2008;88:1278-1290.
58. MacDonald HR, Lees RK, Sordat B, Zaech P, Maryanski JL, Bron C. Age-associated increase in expression of the T cell surface markers Thy-1, Lyt-1, and Lyt-2 in congenitally athymic (nu/nu) mice: Analysis by flow microfluorometry. J Immunol. 1981;126:865-870.
59. Silobrcic V, Zietman AL, Ramsay JR, Suit HD, Sedlacek RS. Residual immunity of athymic NCr/Sed nude mice and the xenotransplantation of human tumors. Int J Cancer 1990;45: 325-333.
60. Zietman AL, Suit HD, Ramsay JR, Silobrcic V, Sedlacek RS. Quantitative studies on the transplantability of murine and human tumors into the brain and subcutaneous tissues of NCr/Sed nude mice. Cancer Res. 1988;48:6510-6516.
61. Wang X, Smith P, Pu LL, Kim YJ, Ko F, Robson MC. Exogenous transforming growth factor beta(2) modulates collagen I and collagen III synthesis in proliferative scar xenografts in nude rats. J Surg Res. 1999;87:194-200.